Incidence and Risk of Infection Associated With Fingolimod in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of 8,448 Patients From 12 Randomized Controlled Trials

Background and Aims: There is a controversy regarding whether fingolimod is associated with an increased risk of infection in patients with multiple sclerosis (MS). We performed a systematic review and meta-analysis of data from randomized controlled trials (RCTs) to determine the risk of infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhao, Ma, Chun-Lai, Gu, Zhi-Chun, Dong, Yue, Lv, Yang, Zhong, Ming-Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982402/
https://www.ncbi.nlm.nih.gov/pubmed/33763062
http://dx.doi.org/10.3389/fimmu.2021.611711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982402/
https://www.ncbi.nlm.nih.gov/pubmed/33763062
http://dx.doi.org/10.3389/fimmu.2021.611711

Ejemplares similares